APA (7th ed.) Citation

F, K., C, O., D, M., JF, C., MA, P., F, C., . . . EM, O. (2025). Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: Clinical insights and genomic features from a large contemporary cohort. Journal of the National Cancer Institute, 117(3), 496. https://doi.org/10.1093/jnci/djae269

Chicago Style (17th ed.) Citation

F, Keane, et al. "Adjuvant Modified FOLFIRINOX for Resected Pancreatic Adenocarcinoma: Clinical Insights and Genomic Features from a Large Contemporary Cohort." Journal of the National Cancer Institute 117, no. 3 (2025): 496. https://doi.org/10.1093/jnci/djae269.

MLA (9th ed.) Citation

F, Keane, et al. "Adjuvant Modified FOLFIRINOX for Resected Pancreatic Adenocarcinoma: Clinical Insights and Genomic Features from a Large Contemporary Cohort." Journal of the National Cancer Institute, vol. 117, no. 3, 2025, p. 496, https://doi.org/10.1093/jnci/djae269.